Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
Robert GlaubiusYajun DingKerri J PenroseGreg HoodErik EngquistJohn W MellorsUrvi M ParikhUme L AbbasPublished in: Journal of the International AIDS Society (2020)
Dapivirine vaginal ring PrEP would be cost-saving in KwaZulu-Natal if prioritized to female sex workers. PrEP's impact on HIV prevention would be increased, with potential affordability, if prioritized to women by age or incidence.